Autolus Therapeutics Appoints Ryan Richardson to Board of Directors

Reuters
2025.12.01 12:00
portai
I'm PortAI, I can summarize articles.

Autolus Therapeutics plc has appointed Ryan Richardson to its Board of Directors. Richardson has over 20 years of experience in strategy and corporate development, previously serving as Chief Strategy Officer at BioNTech. This appointment was announced via GlobeNewswire on December 01, 2025.

Autolus Therapeutics plc has appointed Ryan Richardson to its Board of Directors. Richardson brings over 20 years of experience in strategy and corporate development, having previously served as Chief Strategy Officer at BioNTech and held roles at J.P. Morgan and in life sciences consulting. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Autolus Therapeutics plc published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9594354-en) on December 01, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)

Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer